Overview

Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Status:
Not yet recruiting

Trial end date:
2020-10-01

Target enrollment:

Participant gender:

Summary

This study will be conducted at Children's Healthcare of Atlanta, in Atlanta, Georgia for a total duration of 24 months. The electrical neuromuscular stimulation device used in this study is the Vital EMS+, which has been used in multiple previous clinical studies for modulation of pain and has received FDA approval. A total of 10 study participants will be randomly assigned to one of two groups in the study: 5 will receive the standard of care treatment plus electrical neuromuscular stimulation and 5 will receive standard of care and devices that do not deliver electrical stimulation (sham device). Participants will be requested to deliver nVNS two times per day, at least five days per week in their home, for two years.

Phase:

N/A

Details

Lead Sponsor:

Emory University

Collaborator:

Georgia Institute of Technology

Treatments:

Antibodies
gamma-Globulins
Immunoglobulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin